SPERSADEX COMP.
5MG/ML+1MG/ML OPH GTT SOL 1X5ML I
Announcement of launch, break or close-out of marketing of a medicinal product
| Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
|---|---|---|---|---|
| Interruption of marketing | 14.02.2019 |
0180988, 0225168, 0225172 Léky s jinou kombinací antibiotika a kortikoidu |
Commercial/marketing reasons | 14.08.2019 |
| Interruption of marketing | 19.11.2018 | Léky s jinou kombinací antibiotika a kortikoidu (Dexa-gentamicin ung, Gentadex gtt sol, Maxitrol gtt sus a Tobradex gtt sus) | Manufacturing reasons | 30.12.2018 |
| Resumption of marketing | 18.07.2018 | |||
| Interruption of marketing | 27.06.2018 | Léky s jinou kombinací antibiotika a kortikoidu (Dexa-gentamicin ung, Gentadex gtt sol, Maxitrol gtt sus a Tobradex gtt sus) | ||
| Resumption of marketing | 27.03.2018 | |||
| Interruption of marketing | 06.02.2018 | Léky s jinou kombinací antibiotika a kortikoidu (Dexa-gentamicin ung, Gentadex gtt sol, Maxitrol gtt sus a Tobradex gtt sus) | ||
| Placing on the market | 15.05.2012 |
All reports are available in the Overview.
cz